DHG

CTCP Dược Hậu Giang · HOSE
93,200 Latest close · 30 Jun 2026 P/E 13.3x P/B 2.7x
Showing improvement · CFO/NPAT 0.92x

On a TTM 2026Q1 basis, DHG is improving on both revenue and margins, though the magnitude is still moderate — the growth momentum has held across consecutive periods. This signal only becomes convincing if the improvement continues through the next few periods.

Revenue TTM
VND 5,271bn
+9.3%
Net Margin
17.97%
+0.9pp year on year
ROE
21.5%
TTM

Same sector PHARMACEUTICALS